Fig. 1: Effect of m6A methylation in tumors.
From: Progression of m6A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming
CRC colorectal cancer, ccRCC renal clear cell carcinoma, GC gastric cancer, HCC hepatocellular carcinoma, HNSCC head and neck squamous cell carcinoma, LC lung cancer.
